Olema Pharmaceuticals, Inc. Common Stock
XNAS:OLMA
27.64
$27.67 - 452.00
$27.62 - 16.00
$27.4
$28.62
$27.78
$28.32
29.51
2.86
979707
13935674.4
63383990.1
Chart
TendieTensor AI Analysis
Company
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Fundamentals
117
-15.630000
6.323000
-0.49
100
BBG00T5JMRT4
BBG00T5JMRV1
68.63M
68.63M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own OLMA. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.